Dr David Tovey, Editor-in-Chief, Cochrane, said: "We now have the most robust, comprehensive review on 'neuraminidase inhibitors' that exists. Initially thought to reduce hospitalisations and ...

The use of amantadates for the prevention and treatment of influenza A is more cost-effective than neuraminidase inhibitors; however, they are not effective against influenza B. For this reason ...

Jazz Pharmaceuticals has agreed another pipeline-building deal, this time paying $10 million upfront for rights to a KRAS inhibitor programme from UK biotech Redx Pharma, continuing a move into ...

Mar. 1, 2024 — Researchers have identified antibodies targeting a hard-to-spot region of the influenza virus, shedding light on the relatively unexplored 'dark side' of the neuraminidase (NA ...

Collectively, the eight members of the herpesvirus family are the most common viral pathogens causing disease after SOT. Herpesviruses are large enveloped DNA viruses that commonly reactivate ...

Join MIMS now and pay nothing for the first 30 days Join GPOnline now and pay nothing for the first 30 days ...

Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education and School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan 450001, China ...

Department of Pharmacy, the Second Affiliated Hospital of Wannan Medical College, Wuhu 241000, China Research Center of Integration of Traditional Chinese and Western Medicine, Wannan Medical College, ...